Other languages MiMedx Group, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-05 pm EDT			5-day change	1st Jan Change
6.79 ^USD	-0.44%		-2.02%	-22.58%

Jul. 02	Cantor Fitzgerald Initiates MiMedx at Overweight Rating With $11 Price Target	MT
Jul. 01	MiMedx Group, Inc.(NasdaqCM:MDXG) added to Russell 3000 Growth Index	CI

MiMedx Group, Inc. Announces the Appointment of Kim Moller to Chief Commercial Officer	Jun. 26
MiMedx Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 30
MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products	Mar. 27
MiMedx Group, Inc. Provides Update on AXIOFILL Request for Designation from FDA	Mar. 27
MiMedx Group to Buy Distribution Rights for TELA Bio's Wound Care Product	Mar. 20
MiMedx Launches E-Commerce Platform	Mar. 13
Mimedx Introduces E-Commerce and Account Management Platform	Mar. 13
MiMedx Group, Inc. Announces Appointment of New Independent Directors	Mar. 04
Spectral AI Names Peter Carlson Chief Executive Officer; Reaffirms 2024 Preliminary Revenue Guidance	Mar. 01
MiMedx Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28
MiMedx Group, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28
MÄRKTE USA/Abflauende Zinssenkungsfantasie belastet Aktien	Jan. 02
LATE BRIEFING - Unternehmen und Märkte	Jan. 02
MÄRKTE USA/Abflauende Zinssenkungsfantasie drückt Wall Street ins Minus	Jan. 02
MÄRKTE USA/Jahresstart im Minus - Zinssenkungsfantasie flaut ab	Jan. 02
MÄRKTE USA/Verhaltener Start erwartet - China-Daten belasten	Jan. 02
MIDDAY BRIEFING - Unternehmen und Märkte	Jan. 02
MARKT USA/Verhaltener Start erwartet - China-Daten belasten	Jan. 02
MORNING BRIEFING - USA/Asien	Jan. 02
MiMedx reports US FDA warning letter for Axiofill, shares drop	Dec. 29

No results for this search